SANQUINI RICHARD L 4

4 · SYNAPTICS Inc · Filed May 13, 2020

Form 4

Period: 2020-05-11

Director

Transactions

Exercise/Conversion
Common Stock
2020-05-11$46.50/sh+1,125$52,313→ 30,597 total
Sale
Common Stock
2020-05-11$65.32/sh−7,900$516,008→ 21,572 total
Sale
Common Stock
2020-05-11$67.14/sh−607$40,754→ 14,865 total
Sale
Common Stock
2020-05-11$67.14/sh−1,125$75,533→ 29,472 total
Sale
Common Stock
2020-05-11$65.94/sh−6,100$402,210→ 15,472 total
Exercise/Conversion
Director Stock Option (Right to Buy)
2020-05-11−1,125→ 0 total
Exercise: $46.50Exp: 2020-10-28→ Common Stock (1,125 underlying)

Holdings

Footnotes (6)

[F1]The shares were sold pursuant to a 10b5-1 Trading Plan dated February 19, 2020.
[F2]The shares were sold pursuant to a 10b5-1 Sales Plan dated February 20, 2020.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.67 to $65.64, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.675 to $66.58, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F5]The shares are held by the reporting person as Trustee of the Sanquini 2002 Living Trust, dated January 22, 2002.
[F6]1/12th of the total number of shares subject to the option vested and became exercisable on the 28th day of each month until fully vested on October 28, 2014.

Documents

1 file